The evolution of RTOG and NRG Oncology CNS tumors clinical trials - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Development of Clinical Trials for CNS Tumors by RTOG and NRG Oncology

  • By

  • Kavita Sehrawat

  • Mei-Yin C. Polley

  • Michael A. Vogelbaum

  • Mark Gilbert

  • Arnab Chakravarti

  • Daniel P. Cahill

  • Andrew B. Lassman

  • David R. Raleigh

  • Erik P. Sulman

  • Mitch Machtay

  • Quynh Thu Le

  • Walter Curran

  • Vinai Gondi

  • Minesh P. Mehta

  • September 15, 2026

Share

Original Source(s)

The evolution of RTOG and NRG Oncology CNS tumors clinical trials

  • by Kavita Sehrawat, Mei-Yin C. Polley, Michael A. Vogelbaum, Mark Gilbert, Arnab Chakravarti, Daniel P. Cahill, Andrew B. Lassman, David R. Raleigh, Erik P. Sulman, Mitch Machtay, Quynh Thu Le, Walter Curran, Vinai Gondi, Minesh P. Mehta

  • September 15, 2026

Related Content

Cost-Effectiveness of Electronic Patient-Reported Outcome Measure Interventions in Cancer: Systematic Review and Parameter Extraction for Economic Modeling

Clinician Counseling and Weight Loss Attempts Among Survivors of Obesity-Associated Cancers

AI-Designed Binder Improves CAR T Cell Activity in Mice

Researchers screened 1,758 de novo protein binders and identified design features that influence CAR T cell activation, specificity, and tumor control

  • September 15, 2026

  • 3 min